Erratum: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease (Biometals DOI: 10.1007/s10534-013-9694-3);Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease

BioMetals

Volumn 27, Issue 1, 2014, Pages 207-215

  Grazyna, Gromadzka ^a   Agata, Karpińska ^b   Adam, Przybyłkowski ^b   Tomasz, Litwin ^a   Agata, Wierzchowska Ciok ^a   Karolina, Dziezyc ^a   Grzegorz, Chabik ^a   Anna, Członkowska ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antioxidants; Copper; d Penicillamine; Glutathione peroxidase; Oxidative stress; Treatment; Wilson disease; Zinc sulphate

Indexed keywords

CATALASE; CERULOPLASMIN; COPPER; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; PENICILLAMINE; TRANSFERASE; ZINC SULFATE; ANTIOXIDANT;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CERULOPLASMIN BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; ENZYMATIC ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANGANESE BLOOD LEVEL; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDY; TREATMENT DURATION; WILSON DISEASE; YOUNG ADULT; HEPATOLENTICULAR DEGENERATION; METABOLISM;

ADULT; ANTIOXIDANTS; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; PENICILLAMINE; ZINC SULFATE;

EID: 84893875837     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9706-y     Document Type: Erratum

References (41)

1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson's disease. Lancet 369:397-408 (Pubitemid 46177228)
2. Al-Taie OH, Seufert J, Karvar S, Adolph C, Mörk H, Scheurlen M et al (2003) Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas. Nutr Cancer 46:125-130 (Pubitemid 37500505)
3. Arthur JR (2000) The glutathione peroxidases. Cell Mol Life Sci 57:1825-1835 (Pubitemid 32102578)
4. Bor MV, Cevìk C, Uslu I, Güneral F, Düzgün E (1999) Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol 54:271-276 (Pubitemid 29504935)
5. Bošković M, Vovk T, Kores Plesničar B, Grabnar I (2011) Oxidative stress in schizophrenia. Curr Neuropharmacol 9:301-312
6. Brewer GJ (2000) Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med 223:39-46 (Pubitemid 30182655)
7. Brewer GJ (2005) Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs 19:185-192 (Pubitemid 40460659)
8. Brigelius-Flohé R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830:3289-3303
9. Bruha R, Vitek L, Marecek Z, Pospisilova L, Nevsimalova S, Martasek P et al (2012) Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J Inherit Metab Dis 35:541-548
10. Chaudiere J, Tappel AL (1984) Interaction of gold(I) with the active site of selenium-glutathione peroxidase. J Inorg Biochem 20:313-325
11. Chaudiere J, Wilhelmsen EC, Tappel AL (1984) Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acids and other mercaptans. J Biol Chem 259:1043-1050 (Pubitemid 14196429)
12. Ercal N, Gurer-Orhan H, Aykin-Burns N (2001) Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 1:529-539
13. Fatemi N, Sarkar B (2002) Molecular mechanism of copper transport in Wilson disease. Environ Health Perspect 110(Suppl 5):695-698 (Pubitemid 35276851)
14. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I et al (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139-142 (Pubitemid 37265785)
15. Ferenci P, Członkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C et al (2007) Late-onset Wilson's disease. Gastroenterology 132:1294-1298 (Pubitemid 46627596)
16. Flohe L, Günzler WA, Schock HH (1973) Glutathione peroxidase: a selenoenzyme. FEBS Lett 32:132-134
17. Gaetke M, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189:147-163 (Pubitemid 36725029)
18. Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29:1106-1114
19. Gromadzka G, Schmidt HH, Genschel J, Bochow B, Rodo M, Tarnacka B et al (2005) Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet 68:524-532 (Pubitemid 41748852)
20. Gromadzka G, Chabik G, Mendel T, Wierzchowska A, Rudnicka A, Czlonkowska A (2010) Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism. J Genet 89:463-467
21. Joyce DA (1991) In vitro mechanism of oxidation of d-penicillamine in plasma. J Pharm Sci 80:289-292
22. Kühn H, Borchert A (1987) Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic Biol Med 33:154-172
23. Lynch SM, Frei B (1993) Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 34:1745-1753 (Pubitemid 23298718)
24. Makropoulos V, Brening T, Schulze-Osthoff K (1996) Selenium-mediated inhibition of transcription factor 78 F-k-B and HIV-1 LTR promoter activity. Arch Toxicol 70(5):277-283 (Pubitemid 26053915)
25. Mercer JF (2001) The molecular basis of copper-transport diseases. Trends Mol Med 7(2):64-69 (Pubitemid 33718644)
26. Mercurio SD, Combs GF Jr (1985) Drug-induced changes in selenium-dependent glutathione peroxidase activity in the chick. J Nutr 115:1459-1470 (Pubitemid 16234422)
27. Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K et al (2006) Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res 60:472-477 (Pubitemid 44427603)
28. Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC (1994) Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 3:1647-1656 (Pubitemid 24295463)
29. Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H (2001) Profiles of antioxidants in human plasma. Free Radic Biol Med 30:456-462 (Pubitemid 32162953)
30. Ravin HA (1961) An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 58:161-168
31. Riordan SM, Williams R (2001) The Wilson's disease gene and phenotypic diversity. J Hepatol 34:165-171 (Pubitemid 32102569)
32. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD) (2008) Diagnosis and treatment of Wilson disease: an update. Hepatology 47:2089-2111 (Pubitemid 351945575)
33. Roy G, Sarma BK, Phadnis PP, Mugesh G (2005) Selenium-containing enzymes in mammals: chemical perspectives. J Chem Sci 117:287-303 (Pubitemid 41172404)
34. Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B, Piette J (1994) Stimulation of glutathione peroxidase activity decreases HIV type activation after oxidative stress. AIDS Res Hum Retrovir 10:1451-1461 (Pubitemid 24382197)
35. Schnabel R, Lubos E, Messow CM, Sinning CR, Zeller T, Wild PS et al (2008) Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J 156:1201
36. Spallholz JE (1990) Selenium and glutathione peroxidase: essential nutrient and antioxidant component of the immune system. Adv Exp Med Biol 262:145-158
37. Starkebaum G, Root RK (1993) d-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation. J Immunol 134:3371-3378
38. Terada K, Schilsky ML, Miura N, Sugiyama T (1998) ATP7B (WND) protein. Int J Biochem Cell Biol 30:1063-1067 (Pubitemid 28484828)
39. Ursini F, Bindoli A (1987) The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 44:255-276 (Pubitemid 17146547)
40. Xu SQ, Zhu HY, Lin JG, Su TF, Liu Y, Luo XP (2013) Copper ions stimulate the proliferation of hepatic stellate cells via oxygen stress in vitro. J Huazhong Univ Sci Technol Med Sci 233:75-80
41. Yamamoto H, Watanabe T, Mizuno H, Endo K, Hosokawa T, Kazusaka A et al (2001) In vivo evidence for accelerated generation of hydroxyl radicals in liver of long-evans cinnamon (LEC) rats with acute hepatitis. Free Radic Biol Med 30:547-554 (Pubitemid 32162961)